Global lifetime risk of developing myocarditis, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.

ABSTRACT:

Objectives

Age-standardised incidence rates of myocarditis have been widely reported; this metric primarily provides a cross-sectional view of risk based on a fixed standard population and does not capture the effects of population ageing. Lifetime risk represents the probability of developing myocarditis over an individual's lifespan and incorporates both demographic ageing and competing mortality, thereby offering a complementary perspective that reflects the burden experienced in real-world populations. This study aimed to estimate the global lifetime risk of myocarditis.

Design

This was a systematic analysis using publicly available aggregated data from Global Burden of Disease Study 2021.

Setting

The study included 204 countries and territories from 1990 to 2021.

SUBMITTER: Ji C 

PROVIDER: S-EPMC12815115 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature